Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

Neurology

Volumn 72, Issue 8, 2009, Pages 712-717

  Magana S M ^a   Matiello, M ^a   Pittock, S J ^a   McKeon, A ^a   Lennon, V A ^a,b   Rabinstein, A A ^a   Shuster, E ^c   Kantarci, O H ^a   Lucchinetti, C F ^a   Weinshenker, B G ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; GADOLINIUM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; UNCLASSIFIED DRUG; ANTIBODY; AQUAPORIN 4; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BRAIN EDEMA; CEREBELLUM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONFUSION; CONSCIOUSNESS DISORDER; CONTRAST ENHANCEMENT; DRUG MEGADOSE; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; HYPERTENSION; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; ORTHOSTATIC HYPOTENSION; PARIETAL LOBE; PLASMAPHERESIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; ADOLESCENT; AUTOIMMUNITY; BLOOD; BODY WATER; BRAIN; CEREBROVASCULAR DISEASE; DIFFUSION WEIGHTED IMAGING; DOSE RESPONSE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL ASPECT; REMISSION; SYNDROME; TIME;

ADOLESCENT; ADULT; ANTIBODIES; AQUAPORIN 4; AUTOIMMUNITY; BODY WATER; BRAIN; BRAIN EDEMA; CEREBROVASCULAR DISORDERS; CHILD; COMORBIDITY; CONFUSION; CONSCIOUSNESS DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; METHYLPREDNISOLONE; MIDDLE AGED; NEUROMYELITIS OPTICA; REMISSION, SPONTANEOUS; SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 62349119109     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000343001.36493.ae     Document Type: Article

References (30)

1. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988;45:1078-1083.
2. Schwaighofer BW, Hesselink JR, Healy ME. MR demonstration of reversible brain abnormalities in eclampsia. J Comput Assist Tomogr 1989;13:310-312.
3. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
4. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. A JNR Am J Neuroradiol 1991;12:651-659.
5. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroim-aging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683-688.
6. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996;40:575-580.
7. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467-472.
8. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93-100.
9. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
10. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
11. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477.
12. de Seze J, Arndt C, Jeanjean L, et al. Relapsing inflammatory optic neuritis: is k neuromyelitis optica? Neurology 2008;70:2075-2076.
13. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008;70:2197-2200.
14. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59: 566-569.
15. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003;4: 991-1001.
16. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
17. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968.
18. Poppe AY, Lapierre Y, Melancon D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005; 11:617-621.
19. Matsushita T, Matsuoka T, Ishizu T, et al. Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study. Mult Scler 2008;14:343-353.
20. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205-210.
21. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320-1327.
22. McKinney AM, Short J, Truwh CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-912.
23. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-1048.
24. Eichel R, Meiner Z, Abramsky O, Gotkine M. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol 2008;65:267-271.
25. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJRAm J Roentgenol 1992;159:379-383.
26. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000;6:159-163.
27. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004;18:1291-1293.
28. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461.
29. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007;130: 1194-1205.
30. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007;69:2221-2231.